483 related articles for article (PubMed ID: 6676604)
21. Effects of the anti-dementia drug hopantenate calcium upon striatal dopaminergic neurons in young and aged rats.
Toide K
Arch Int Pharmacodyn Ther; 1989; 299():7-13. PubMed ID: 2570556
[TBL] [Abstract][Full Text] [Related]
22. A comparison between classes of drugs having phencyclidine-like behavioral properties on dopamine efflux in vitro and dopamine metabolism in vivo.
Snell LD; Mueller ZL; Gannon RL; Silverman PB; Johnson KM
J Pharmacol Exp Ther; 1984 Nov; 231(2):261-9. PubMed ID: 6092611
[TBL] [Abstract][Full Text] [Related]
23. Prolactin regulation of tuberoinfundibular dopaminergic neurons: immunoneutralization studies.
Hentschel K; Fleckenstein AE; Toney TW; Lawson DM; Moore KE; Lookingland KJ
Brain Res; 2000 Jan; 852(1):28-36. PubMed ID: 10661492
[TBL] [Abstract][Full Text] [Related]
24. Effect of beta-endorphin on striatal dopamine metabolism.
Van Loon GR; Kim C
Res Commun Chem Pathol Pharmacol; 1977 Sep; 18(1):171-4. PubMed ID: 905630
[TBL] [Abstract][Full Text] [Related]
25. Modulation of striatal enkephalinergic neurons by antipsychotic drugs.
Hong JS; Yoshikawa K; Kanamatsu T; Sabol SL
Fed Proc; 1985 Jun; 44(9):2535-9. PubMed ID: 3838946
[TBL] [Abstract][Full Text] [Related]
26. Modulatory role for prolactin in the elevation of striatal dopamine receptor density induced by chronic treatment with dopamine receptor antagonists.
Hruska RE
Brain Res Bull; 1986 Mar; 16(3):331-9. PubMed ID: 3708389
[TBL] [Abstract][Full Text] [Related]
27. Reproductive experience increases striatal and hypothalamic dopamine levels in pregnant rats.
Felicio LF; Florio JC; Sider LH; Cruz-Casallas PE; Bridges RS
Brain Res Bull; 1996; 40(4):253-6. PubMed ID: 8842408
[TBL] [Abstract][Full Text] [Related]
28. Effects of experimentally induced ischemia on dopamine metabolism in rabbit retina.
Cao W; Drumheller A; Zaharia M; Lafond G; Brunette JR; Jolicoeur FB
Invest Ophthalmol Vis Sci; 1993 Oct; 34(11):3140-6. PubMed ID: 8407222
[TBL] [Abstract][Full Text] [Related]
29. Stimulatory control of prolactin by dopamine.
Brown GM; Seggie JA
Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):355-8. PubMed ID: 6891802
[TBL] [Abstract][Full Text] [Related]
30. Interactions of dopaminergic and peptidergic factors in the control of prolactin release.
Mogg RJ; Samson WK
Endocrinology; 1990 Feb; 126(2):728-35. PubMed ID: 2298169
[TBL] [Abstract][Full Text] [Related]
31. Differential effect of acute and chronic haloperidol administration on dopamine turnover in rat nigrostriatal and retinal dopaminergic neurons.
Melamed E; Durst R; Frucht Y; Globus M
Eur J Pharmacol; 1983 May; 89(3-4):279-82. PubMed ID: 6873163
[TBL] [Abstract][Full Text] [Related]
32. Effect of haloperidol on cyclic AMP and inositol trisphosphate in rat striatum in vivo.
Kaneko M; Sato K; Horikoshi R; Yaginuma M; Yaginuma N; Shiragata M; Kumashiro H
Prostaglandins Leukot Essent Fatty Acids; 1992 May; 46(1):53-7. PubMed ID: 1378633
[TBL] [Abstract][Full Text] [Related]
33. Ganglioside interactions with the dopaminergic system of rats.
Tilson HA; Harry GJ; Nanry K; Hudson PM; Hong JS
J Neurosci Res; 1988; 19(1):88-93. PubMed ID: 3125345
[TBL] [Abstract][Full Text] [Related]
34. Regulation of the synthesis and metabolism of striatal dopamine after disruption of nerve conduction in the medial forebrain bundle.
Commissiong JW; Slimovitch C; Toffano G
Br J Pharmacol; 1990 Apr; 99(4):741-9. PubMed ID: 2361171
[TBL] [Abstract][Full Text] [Related]
35. Dopamine metabolism in the striatum of hemiparkinsonian model rats with dopaminergic grafts.
Hashitani T; Mizukawa K; Kumazaki M; Nishino H
Neurosci Res; 1998 Jan; 30(1):43-52. PubMed ID: 9572579
[TBL] [Abstract][Full Text] [Related]
36. [Effects of anticholinergics and clozapine on the activation of the striatal dopaminergic system in the rat by haloperidol. Neurochemical findings (author's transl)].
Bürki HR; Sayers AC; Ruch W; Asper H
Arzneimittelforschung; 1976; 26(6):1094-6. PubMed ID: 989385
[TBL] [Abstract][Full Text] [Related]
37. Chronic cocaine and rat brain catecholamines: long-term reduction in hypothalamic and frontal cortex dopamine metabolism.
Karoum F; Suddath RL; Wyatt RJ
Eur J Pharmacol; 1990 Sep; 186(1):1-8. PubMed ID: 2282931
[TBL] [Abstract][Full Text] [Related]
38. CI-943, a potential antipsychotic agent. II. Neurochemical effects.
Pugsley TA; Coughenour LL; Myers SL; Shih YH; Courtland GG; Berghoff W; Stewart SF
J Pharmacol Exp Ther; 1989 Oct; 251(1):113-22. PubMed ID: 2571713
[TBL] [Abstract][Full Text] [Related]
39. Different effects of metoclopramide and domperidone on GH release in type I male diabetics.
Volpi R; Coiro V; Castelli A; Cappagli M; Muzzetto P; Sciarra A; Chiodera P
Horm Metab Res; 1984 Dec; 16 Suppl 1():131-3. PubMed ID: 6532934
[TBL] [Abstract][Full Text] [Related]
40. Effect of chronic haloperidol treatment on stimulated synaptic overflow of dopamine in the rat striatum.
Wiedemann DJ; Garris PA; Near JA; Wightman RM
J Pharmacol Exp Ther; 1992 May; 261(2):574-9. PubMed ID: 1533666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
